A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy-Reference-Cited by-同舟云学术

A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy

Published:2012-03-11 Issue:2 Volume:34 Page:197-203
ISSN:1590-1874
Container-title:Neurological Sciences
language:en
Short-container-title:Neurol Sci

Author:

Annovazzi Pietro,Tomassini Valentina,Bodini Benedetta,Boffa Laura,Calabrese Massimiliano,Cocco Eleonora,Cordioli Cinzia,De Luca Giovanna,Frisullo Giovanni,Gallo Antonio,Malucchi Simona,Paolicelli Damiano,Pesci Ilaria,Radaelli Marta,Ragonese Paolo,Roccatagliata Luca,Tortorella Carla,Vercellino Marco,Zipoli Valentina,Gasperini Claudio,Rodegher Mariaemma,Solaro Claudio

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Clinical Neurology,Dermatology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10072-012-0981-5.pdf

Reference35 articles.

1. Confavreux C, Vukusic S, Adeleine P (2003) Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 126(Pt 4):770–782

2. Lublin FD, Baier M, Cutter G (2003) Effect of relapses on development of residual deficit in multiple sclerosis. Neurology 61(11):1528–1532

3. Vukusic S, Confavreux C (2007) Natural history of multiple sclerosis: risk factors and prognostic indicators. Curr Opin Neurol 20(3):269–274

4. Halper J (2007) The psychosocial effect of multiple sclerosis: the impact of relapses. J Neurol Sci 256(Suppl 1):S34–S38

5. Pozzilli C, Palmisano L, Mainero C, Tomassini V, Marinelli F, Ristori G, Gasperini C, Fabiani M, Battaglia MA (2004) Relationship between emotional distress in caregivers and health status in persons with multiple sclerosis. Mult Scler 10(4):442–446

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of oral prednisolone tapering following intravenous methyl prednisolone in patients with multiple sclerosis relapses: A randomized, double-blind, placebo-controlled trial;Multiple Sclerosis and Related Disorders;2021-01